Jazz Pharmaceuticals Denmark ApS: Financial statements 2021
CVR: 39791447
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Jazz Pharmaceuticals Denmark ApS (CVR 39791447) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 21,713,525 and a net result of DKK 560,263 compared with DKK 1,540,505 the year before. That is an increase of 31.8% compared with the year before. Equity in the 2021 report amounted to DKK 8,188,785. The solvency ratio was 39%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 21,713,525
- Profit/Loss
- DKK 560,263
- Equity
- DKK 8,188,785
- Total Assets
- DKK 21,013,537
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 21.7 mio. | 560 t. | 8.2 mio. | 10 |
| 2020 | - | 16.5 mio. | 1.5 mio. | 7.6 mio. | 14 |
Official annual report
Find more companies like Jazz Pharmaceuticals Denmark ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 20, 2021, is registered as an owner of Jazz Pharmaceuticals Denmark ApS with an ownership share of 100%.
Jazz Pharmaceuticals Denmark ApS has published its annual report for 2020. Gross profit came to DKK 16,469,482, and the net result was DKK 1,540,505.
As of May 21, 2021, KPMG P/S has been appointed auditor of Jazz Pharmaceuticals Denmark ApS.
As of April 22, 2021, Samantha Jane Laura Pearce is registered as director of Jazz Pharmaceuticals Denmark ApS.
As of April 22, 2021, Joseph Dagher has stepped down as director of Jazz Pharmaceuticals Denmark ApS.
About Jazz Pharmaceuticals Denmark ApS
Jazz Pharmaceuticals Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of David James Spackman and Kamilla Enggaard Have. The company is owned by Jazz Pharmaceuticals Ireland Holdings Limited. The company has 13 employees (2026). In 2025, the company reported a gross profit of DKK 41,044,332 and a net result of DKK 1,528,396 compared with DKK 1,538,214 the year before. Equity in the 2025 report amounted to DKK 13,823,507.